Search

everythinglearnresearchcommunity

for

Search:↓

Scientists successfully created mouse hair proteins in the lab, which are stable and similar to natural hair.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

Skin stem cells maintain and repair the outer layer of skin, with some types being essential for healing wounds.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Finasteride may cause floppy-iris syndrome during cataract surgery, so check patients' medical history.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

Different skin stem cells help heal wounds, with hair follicle cells becoming more important over time.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

High glycine–tyrosine keratin-associated proteins help make hair strong and maintain its shape.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

The document concludes that advanced methods show the presence of P. acnes in acne lesions but do not prove it causes acne.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Alopecia Areata might be linked to Crohn's disease.

Type I interferons play a key role in the development of various skin diseases.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.